Covid-19 Vaccine

Vietnam has started the final stage phase III trials of its domestically developed coronavirus vaccine candidate that the country expects to roll out for mass use by the end of the year, according to a NikkeiAsia report from Hanoi.…

The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price and clearly not sustainable in the long run. Hence a higher price in private markets is required to offset part of the costs, Bharat Biotech…

Two doses of Pfizer and AstraZeneca's Covid-19 vaccines are highly effective against hospitalisation from the Delta (B16172) variant, according to new analysis from Public Health England (PHE). The analysis suggests that the Pfizer-BioNTech…

The 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development organisation (DRDO) for the coronavirus treatment, effectively inhibits the SARS-CoV-2 multiplication and works against all variants of Covid-19, says a research…

Researchers have found that coronavirus disease can cause severe inflammation in the central nervous system. The study, led by a team of researchers from the University of Freiburg in Germany, showed that a severe inflammatory response can…

US-based biotechnology company Novavax's protein-based vaccine has shown overall 90 per cent efficacy against Covid-19, results of Phase-3 trials have shown. The vaccine NVX-CoV2373 is already being locally manufactured by the company's…

Iranian Health Minister Saeed Namaki has announced the emergency use of a domestic vaccine for Covid-19. The emergency use of COVIran Barakat financed by the Barakat Foundation has been authorised, Namaki said at a conference in the central…

AstraZeneca's Covid-19 vaccine remains authorised for all populations, European Medicines Agency (EMA) has said.The clarification camme after Italian newspaper La Stampa earlier quoted Marco Cavaleri, head of the EMA's vaccine strategy,…

The All India Institute of Medical Sciences (AIIMS) is learnt to have started screening of children aged 6-12 years for the clinical trials of India's first indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin.Sources said that…

A single dose of vaccine is sufficient for those already infected by Covid-19, revealed a study by Hyderabad's AIG Hospitals.The hospital announced on Monday that it conducted a study on 260 healthcare workers who got vaccinated between…